Tema Etfs LLC Mereo Biopharma Group PLC Transaction History

Tema Etfs LLC

  • $1.2 Trillion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$1.76 - $2.87 $971,666 - $1.58 Million
-552,083 Reduced 84.33%
102,583 $278 Million
Q1 2025

May 14, 2025
SELL
$2.25 - $3.76 $530,734 - $886,916
-235,882 Reduced 26.49%
654,666 $1.47 Billion
Q4 2024

Feb 14, 2025
BUY
$3.29 - $4.62 $2.93 Million - $4.11 Million
890,548 New
890,548 $3.12 Billion

Others Institutions Holding MREO

# of Institutions
96
Shares Held
99.9M
Call Options Held
2.23M
Put Options Held
179K
View Full List

About Mereo Biopharma Group plc

MREO Quotes by TradingView
  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $227M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track This Portfolio

Track Tema Etfs LLC Portfolio

Follow Tema Etfs LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tema Etfs LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tema Etfs LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email